Loading...
The Role of Galcanezumab in Migraine Prevention: Existing Data and Future Directions
Galcanezumab is a humanized monoclonal antibody blocking the calcitonin gene-related peptide (CGRP) pathway by targeting the CGRP. Data from four phase-3 randomized placebo-controlled clinical trials showed that galcanezumab is superior to placebo in reducing migraine headaches, migraine-specific qu...
Na minha lista:
| Udgivet i: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7998387/ https://ncbi.nlm.nih.gov/pubmed/33803190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14030245 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|